… enough, since the plasma levels are largely affected by … in blood plasma, to be crucial potential
AD biomarkers for future … blood plasma to be a highly sensitive and specific biomarker for …

… several plasma biomarkers but most frequently plasma amyloid … use of genetic variants as
biomarkers for diagnosis or risk. … regarding plasma Aβ40 and Aβ42 as diagnostic biomarkers …

… This has highlighted the need for reliable and convenient biomarkers for both early disease
… biomarkers in patients with Alzheimer's disease and the correlation of those biomarkers with …

… of CSF biomarkers is limited by the invasive nature of lumbar puncture. Plasma biomarkers
require only peripheral blood sampling, facilitating longitudinal monitoring of disease …

… Petrie, MD, PhD, from the University of Glasgow for participating as investigators in the
trial and Shorena Janelidze, PhD, from Lund University for participating in plasma biomarker …

… blood plasma samples are arguably less invasive and more routinely obtained than CSF
samples, we examined plasma proteomic biomarkers as an alternative to CSF biomarkers. …

… , early/late MCI and dementia), but excluding the participants of this study with plasma
biomarker data. The method yields a probabilistic score of Aβ-positivity between 0 and 1. …

… ) have evolved as prime targets for biomarker investigation. This review … plasma and CSF
as candidate biomarkers for AD, and briefly discusses advances in potential urinary biomarkers …

… of different plasma biomarkers would increase the prognostic accuracy. For this purpose,
we considered not only the misfolding of Aβ but also the plasma Aβ 42/40 ratio level. …

… used as a plasma biomarker for AD. In this study, we aimed to determine whether plasma
cathepsin D could be a useful biomarker for AD diagnosis. We found that plasma cathepsin D …